A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD

Completed · Phase 3

Conditions studied: Chronic Obstructive Pulmonary Disease

In brief

The purpose of this study is to determine if SYMBICORT® delivered via a pressurized metered-dose inhaler, referred to as a pMDI, is effective in preventing COPD exacerbations.

Key facts

Study ID

NCT00419744

Run by

AstraZeneca

People needed

1200

Starts

2007-01-01

Expected to finish

2009-08-01

Last updated by the study team

2010-09-16

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A current clinical diagnosis of COPD with COPD symptoms for more than 2 years
• Current smoker or smoking history of 10 or more pack years (1 pack year = 20 cigarettes smoked per day for one year)
• A history of at least 1 COPD exacerbations requiring a course of steroids and/or antibiotics within 1-12 months before the first visit

You may not qualify if…

• A history of asthma at or after 18 years of age
• A history of allergic rhinitis at or after 18 years of age
• Subjects taking oral steroids
• Any significant disease or disorder that may jeopardize a subject's safety

Where it is running

• Research Site — McKinney, Texas, United States
• Research Site — San Antonio, Texas, United States
• Research Site — Abingdon, Virginia, United States
• Research Site — Spokane, Washington, United States
• Research Site — Tacoma, Washington, United States
• Research Site — Capital Federal, Buenos Aires, Argentina
• Research Site — Mar del Plata, Buenos Aires, Argentina
• Research Site — Nueve de Julio, Buenos Aires, Argentina
• Research Site — Ramos Mejía, Buenos Aires, Argentina
• Research Site — Vicente López, Buenos Aires, Argentina
• Research Site — Corrientes, Corrientes Province, Argentina
• Research Site — Córdoba, Córdoba Province, Argentina
• Research Site — Mendoza, Mendoza Province, Argentina
• Research Site — San Juan, San Juan Province, Argentina
• Research Site — San Miguel de Tucumán, Tucumán Province, Argentina
• Research Site — Fortaleza, Ceará, Brazil
• Research Site — Goiânia, Goiás, Brazil
• Research Site — Curitiba, Paraná, Brazil
• Research Site — Recife, Pernambuco, Brazil
• Research Site — Rio de Janeiro, Rio de Janeiro, Brazil
• Research Site — Porta Alegre, Rio Grande do Sul, Brazil
• Research Site — Porto Alegre, Rio Grande do Sul, Brazil
• Research Site — Florian�polis, Santa Catarina, Brazil
• Research Site — Santo André, São Paulo, Brazil
• Research Site — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.